Dermata Therapeutics, Inc. - Common Stock (DRMA)

U.S. stock futures fell on Friday after two consecutive days of decline on Wednesday and Thursday. Futures of benchmark indices were lower.

Dermata Therapeutics stock is up on Wednesday with heavy trading of the company's shares despite a lack of news this morning.

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Dermata's Xyngari showed significant acne improvement in Phase 3 results. A second pivotal trial is set for the second half of 2025.

If your growth stocks have stopped growing then you may be holding on to F-rated growth stocks. It's time to sell.

DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!

Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares are trading higher Wednesday. Here's what you need to know.

Azitra stock is falling on Wednesday as shares of AZTR come off of a massive rally yesterday alongside a new patent update.

Nuzee stock is up on Wednesday with heavy trading of NUZE shares despite a lack of news from the coffee machine company.

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!